Cargando…

1071. Social Determinants of health (SDOH) among PWID living with HCV

BACKGROUND: Though people who inject drugs (PWID) represent the overwhelming majority of those living with HCV, most have not been treated. Many HCV+ PWID represent the most marginalized persons in society, often experiencing poverty and poor access to care. We set out to determine the social determ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corro, Luis Gonzalez, Gutierrez, Nataly Rios, Cunningham, Chinazo O, Litwin, Alain H, Norton, Brianna L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777302/ http://dx.doi.org/10.1093/ofid/ofaa439.1257

Ejemplares similares

1062. HCV GET-UP: A Group Evaluation and Treatment Uptake Intervention Improves HCV Linkage to Care for PWID
por: Norton, Brianna L, et al.
Publicado: (2020)

2497. Analysis of Social Determinants of Health (SDOH) and their Implications for Hepatitis C Treatment in People Who Inject Drugs: The Case of Baltimore
por: Corro, Luis A Gonzalez, et al.
Publicado: (2023)

Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral Agents
por: Norton, Brianna L, et al.
Publicado: (2020)

Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial
por: Pericot-Valverde, Irene, et al.
Publicado: (2020)

Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy
por: Akiyama, Matthew J., et al.
Publicado: (2018)

P1071: IMPACT OF ACETYLSALICYLIC ACID DOSAGE ON INCIDENCE OF THROMBOSIS AND MORTALITY IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS.
por: Wild, A., et al.
Publicado: (2022)

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
por: Tsui, Judith I., et al.
Publicado: (2016)

1071. Impact of volume resuscitation on heart rate variability in a model of hemorrhagic shock in pigs
por: Salomão, E, et al.
Publicado: (2014)

Effectiveness of alternative approaches to integrating SDOH into medical education: a scoping review
por: Nour, Nehal, et al.
Publicado: (2023)

PCR55 Analyzing the Relationship between Social Determinants of Health (SDOH) on Hospital Capacity for COVID-19 Patients By Geographic Region
por: Watkins, K, et al.
Publicado: (2022)

Whole Child Well-Child Visits: Implementing ACEs and SDOH Screenings in Primary Care
por: Yaun, Jason A., et al.
Publicado: (2022)

Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention
por: Walters, Suzan M., et al.
Publicado: (2021)

695. Infective endocarditis in people who inject drugs (PWID) at UK Medical Center
por: Cari, Evelyn Villacorta, et al.
Publicado: (2020)

D10.7.1: Results of slice measurements
por: Rudolph, J
Publicado: (2011)

The relationship between Social Determinants of Health (SDoH) and death from cardiovascular disease or opioid use in counties across the United States (2009–2018)
por: Rangachari, Pavani, et al.
Publicado: (2022)

Predisposing, enabling, and need factors associated with utilization of HCV testing services among PWID in two settings in India
por: Sogarwal, Ruchi, et al.
Publicado: (2016)

536. HIV Patients with COVID-19 in the Bronx: A Retrospective Cohort Study
por: Lee, Philip J, et al.
Publicado: (2020)

Declines in Depressive Symptoms Among People who Inject Drugs Treated With Direct-Acting Antivirals While on Opioid Agonist Therapy
por: Pericot-Valverde, Irene, et al.
Publicado: (2020)

P1071: COMBINATION OF PD-1 INHIBITION WITH IMMUNOMODULATORY DRUG TREATMENT IN HODGKIN AND LARGE B-CELL LYMPHOMA: RESULTS FROM A PHASE I/II STUDY
por: Bond, David, et al.
Publicado: (2023)

Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico
por: Abadie, Roberto, et al.
Publicado: (2016)

Establishing trust in HIV/HCV research among people who inject drugs (PWID): Insights from empirical research
por: Abadie, Roberto, et al.
Publicado: (2018)

2900. High Rates of Experienced and Witnessed Opioid Overdose in PWID Receiving HCV Treatment: Data From the ANCHOR Study
por: Rosenthal, Elana S, et al.
Publicado: (2019)

1050. Hepatitis C Infection amongst People who Inject Drugs (PWID): Injection Practices and Risk Factors
por: Sankar, Nityasri, et al.
Publicado: (2020)

Artificial Intelligence Platform Demonstrates High Adherence in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study
por: Litwin, Alain H, et al.
Publicado: (2020)

Hepatitis C Resistance-Associated Substitutions Among People Who Inject Drugs Treated With Direct-Acting Antiviral-Containing Regimens
por: Akiyama, Matthew J, et al.
Publicado: (2021)

More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study
por: Heo, Moonseong, et al.
Publicado: (2022)

A Birth-cohort testing intervention identified hepatitis c virus infection among patients with few identified risks: a cross-sectional study
por: Southern, William N., et al.
Publicado: (2015)

Community-based HCV screening: knowledge and attitudes in a high risk urban population
por: Norton, Brianna L, et al.
Publicado: (2014)

2897. Collocated Buprenorphine Is Associated with Improved HCV Visit Adherence in People Who Inject Drugs (PWID): Data From the ANCHOR Study
por: Rosenthal, Elana S, et al.
Publicado: (2019)

Current management options for latent tuberculosis: a review
por: Norton, Brianna L, et al.
Publicado: (2012)

1071. Efficacy of Anti-Staphylococcal Lysin, LSVT-1701, in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis (IE) Due to Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Huang, David, et al.
Publicado: (2021)

Changes in alcohol use during hepatitis C treatment in persons who inject drugs
por: Martin, Madhuri, et al.
Publicado: (2022)

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)
por: Barré, Tangui, et al.
Publicado: (2019)

225. Dalbavancin Usage in Patients Who Inject Drugs (PWID)
por: Patel, Kaya, et al.
Publicado: (2023)

Intermittent Negative Blood Cultures in Staphylococcus aureus Bacteremia; a Retrospective Study of 1071 Episodes
por: Stewart, James D, et al.
Publicado: (2019)

A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives
por: May, Tom, et al.
Publicado: (2022)

Viral load testing to monitor the HIV epidemic among PWID in Vietnam
por: Khuu, Nghia V., et al.
Publicado: (2018)

Utilizing clinical pharmacists and a medication assistance program to improve medication access for indigent and underserved patients in primary care
por: Pickett, Brianna, et al.
Publicado: (2022)

Needle acquisition patterns, network risk and social capital among rural PWID in Puerto Rico
por: Duncan, Ian, et al.
Publicado: (2017)

Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients
por: Lee, Se-Hoon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_90bsfef6i3s2kfvdcejd7e98de